Market News AIOpen the app

Disappointing Q2 performance from Swarmers leads to declines alongside TSS, ARS Pharmaceuticals, Globant, and other major stocks in Friday's pre-market trading.

New bossRead the original at benzinga.com
Good for SWMR

Swarmer reported a larger-than-expected loss and lower sales, leading to a sharp decline in share price.

SWMR · Swarmer Inc

AI read · Good for SWMR

The AI's read

Swarmer missed Q2 badly and shares sold off pre-market. The company reported a much larger loss and tiny revenue versus consensus. The market reacted with an initial ~7% pre-market drop, though price has since pared some losses. RSI 66.5 and price below the 20-day suggest the move hasn't fully washed out yet. We lean bearish on SWMR. Fresh earnings miss, $216k revenue, and little visible upside make near-term downside more probable than a quick rebound.

Get alerts for SWMR

Follow Swarmer Inc (SWMR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SWMR
Free on the App Store and Google Play, or on the web.